Page last updated: 2024-08-21

hydrazine and Liposarcoma

hydrazine has been researched along with Liposarcoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Alcindor, T; Attia, S; Badalamenti, G; Ben-Shahar, O; Beveridge, RD; Blay, JY; Burgess, M; Chang, H; Chawla, S; Chen, JL; Chevreau, C; Chmielowski, B; Davis, EJ; Deshpande, H; Dickson, MA; Duffaud, F; Elias, A; Eriksson, M; Forscher, C; Ganjoo, KN; Garcia Del Muro, X; Gonzalez, AE; Götze, K; Gounder, MM; Grignani, G; Gröschel, S; Hartner, L; Hatcher, H; Herráez, AC; Italiano, A; Jones, RL; Kasper, B; Kauffman, MG; Landesman, Y; Lapeire, L; Le Cesne, A; Lee, A; Li, L; Liu, J; Loggers, ET; Martin-Broto, J; Mazzeo, F; Meng, C; Meyer, C; Michel, D; Mulcahy, MF; Napolitano, A; Nicholas, G; Okuno, S; Penel, N; Philip, T; Piperno-Neumann, S; Razak, AA; Reichardt, P; Riedel, RF; Ryan, C; Schuetze, SM; Schwartz, GK; Shacham, S; Shah, JJ; Somaiah, N; Stacchiotti, S; Valverde Morales, CM; Van Domelen, DR; Van Tine, BA; Vincenzi, B; von Mehren, M; Wagner, AJ; Walker, CJ; Yakobson, A; Zick, A1
Dakle, P; Jeitany, M; Jiang, YY; Kanojia, D; Kappei, D; Koeffler, HP; Landesman, Y; Madan, V; Mukundan, V; Pathak, E; Prabhu, A; Tam, WL1
Barisella, M; Brich, S; Casali, PG; Colombo, C; Dagrada, GP; Dei Tos, AP; El Bezawy, R; Gounder, M; Gronchi, A; Lauricella, C; Pasquali, S; Percio, S; Sanfilippo, R; Stacchiotti, S; Tortoreto, M; Zaffaroni, N; Zuco, V1
Abdul Razak, AR; Attia, S; Chawla, SP; Chmielowski, B; Gilligan, AM; Gounder, M; Grignani, G; Jones, RL; Kauffman, M; Leong, H; Ma, X; Martin-Broto, J; Riedel, RF; Schuetze, SM; Shacham, S; Shah, J; Somaiah, N; Vincenzi, B; Wagner, AJ1
Baloglu, E; Chien, W; Chuang, LS; Doan, NB; Ganesan, TS; Garg, M; Kanojia, D; Kauffman, M; Koeffler, HP; Mayakonda, A; Said, JW; Shacham, S; Venkatachalam, N1

Trials

2 trial(s) available for hydrazine and Liposarcoma

ArticleYear
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 08-01, Volume: 40, Issue:22

    Topics: Child; Double-Blind Method; Humans; Hydrazines; Liposarcoma; Triazoles

2022
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
    Future oncology (London, England), 2021, Volume: 17, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Cancer Pain; Cross-Over Studies; Female; Humans; Hydrazines; Liposarcoma; Male; Middle Aged; Neoplasm Staging; Placebos; Quality of Life; Triazoles

2021

Other Studies

3 other study(ies) available for hydrazine and Liposarcoma

ArticleYear
Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas.
    Cellular and molecular life sciences : CMLS, 2021, Volume: 78, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cell Line, Tumor; Cell Nucleus; Drug Resistance, Neoplasm; Drug Synergism; Exportin 1 Protein; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Liposarcoma; Oligopeptides; Piperazines; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptors, Cytoplasmic and Nuclear; Triazoles

2021
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation.
    Journal of experimental & clinical cancer research : CR, 2021, Mar-01, Volume: 40, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Dedifferentiation; Cell Nucleus; Down-Regulation; Doxorubicin; Humans; Hydrazines; Liposarcoma; Male; Mice; Mice, Nude; Random Allocation; Survivin; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2021
Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma.
    Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Aurora Kinase B; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Insulin-Like Growth Factor Binding Protein 5; Karyopherins; Liposarcoma; Male; Mice; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Cytoplasmic and Nuclear; Receptors, Somatomedin; RNA Interference; Signal Transduction; Time Factors; Transfection; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays

2017
chemdatabank.com